Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Cover shows cocooned silkworms in a circular nest at a silk farm. On page 52, Yoshizato and coworkers report collagen production by transgenic silkworms. (Photo courtesy of Stephanie Colasanti/CORBIS).
A survey of the scientific and patent literature on single-nucleotide variants reveals the dominance of research centers in the United States and the prolific patenting of SNP technology by a select group of biotechnology companies.
Two reports demonstrate the specific labeling of cellular constituents with fluorescent quantum dot probes conjugated covalently or electrostatically to antibodies and streptavidin.
Recent court decisions effectively call for researchers and companies to reduce their biotechnology and pharmaceutical inventions to practice before they can apply for patent protection.
